Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
05/2010
05/13/2010US20100120759 Azadecalin glucocorticoid receptor modulators
05/13/2010US20100120755 Conjugated psychotropic drugs and uses thereof
05/13/2010US20100120738 Anti-apoptotic benzodiazepine receptor ligand inhibitors
05/12/2010EP2184285A1 Heterocyclic compound and use thereof
05/12/2010EP2183246A2 2-aza-bicyclo-[3.3.0]-octane derivatives
05/12/2010EP2183232A2 Pi3 kinase modulators and methods of use
05/11/2010US7714004 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
05/11/2010US7714003 Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides
05/11/2010US7713966 Heterobicyclic metalloprotease inhibitors
05/11/2010US7713956 Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/06/2010WO2010049152A1 Novel composition for the preparation of mature dendritic cells
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100113429 Inhibitors of ftsz and uses thereof
05/06/2010US20100113414 Thiazolyl-dihydro-indazoles
05/06/2010CA2779261A1 Filamin a binding anti-inflammatory and analgesic
05/05/2010EP2181996A1 Aminopiperidine derivatives
05/05/2010EP2180893A2 Pharmaceutical compositions and methods for the treatment of cancer
05/05/2010CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases
05/04/2010US7709510 Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
05/04/2010US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/04/2010US7709472 treating bacterial infections; 6-{[((1S,5R,6S)-3-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-azabicyclo[3.2.0]hept-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]-thiazin-3(4H)-one or -oxazin-3(4H)-one; antibiotics; grampositive Staphylococcus, gramnegative Haemophilus, Moraxella, Escherichia
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
04/2010
04/29/2010WO2010046517A1 Compounds promoting the activity of mutant glycosidases
04/29/2010WO2010046388A1 Substituted (aza) -1-methyl-1h-quinolin-2-ones as antibacterials
04/29/2010WO2010045987A1 Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials
04/29/2010WO2010003475A3 Novel pyrrolidone derivatives for use as metap-2 inhibitors
04/29/2010WO2009026446A8 Hdac inhibitors
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/28/2010EP2178886A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections
04/28/2010EP2178885A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections
04/28/2010EP2178882A1 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
04/28/2010EP2178858A1 Novel heterocyclic compounds as mglu5 antagonists
04/28/2010EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators
04/27/2010US7705014 e.g. 2-{4-[(3-hydroxy-4,7-dihydroisoxazolo[5,4-c]pyridin-6(5H)-yl)methyl]phenyl}-3-phenyl-1,6-naphthyridin-5(6H)-one; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity; cancer
04/27/2010US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase
04/27/2010CA2449180C Viral polymerase inhibitors
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/22/2010WO2010045251A2 Spiro-oxindole compounds and their use as therapeutic agents
04/22/2010WO2010044441A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase
04/22/2010WO2010043893A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
04/22/2010US20100099695 HCV NS3 Protease Inhibitors
04/22/2010US20100099662 Hydrazone derivative
04/22/2010US20100099660 Method for treating thrombosis or embolism and related diseases
04/22/2010CA2741029A1 Spiro-oxindole compounds and their use as therapeutic agents
04/22/2010CA2736335A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
04/21/2010EP2176259A1 Fused imidazoles for cancer treatment
04/21/2010EP1963324B1 Heterocyclic compounds, their preparation and their use as antibacterials
04/21/2010EP1891077B1 Monomers , oligomers and polymers of thieno (3, 4-d) thiazole
04/21/2010CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors
04/21/2010CN101696216A Method for preparing 1,3,4-thiadiazole-p-[3,2-alpha] pyridine derivative by one-pot method
04/20/2010US7700635 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitorsfor seine/threonine kinases, phosphatases; Alzheimer's
04/20/2010US7700634 (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
04/20/2010US7700616 Compounds and amyloid probes thereof for therapeutic and imaging uses
04/20/2010US7700609 antiproliferative agents; antiinflammatory agents; neurodegenerative agents; autoimmune disease; viricides
04/20/2010CA2565411C Compounds and methods for inhibiting mitotic progression
04/15/2010WO2010040527A1 Novel compounds which modulate kinase activity
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093785 Diamine derivatives
04/15/2010US20100093777 Spiro-ring compound
04/15/2010US20100093689 Heteroaryl compounds as p2y1 receptor inhibitors
04/14/2010EP2173717A2 Novel glucokinase activators and methods of using same
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/13/2010US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/08/2010WO2010038686A1 Novel fused aminodihydrothiazine derivative
04/08/2010WO2010038060A1 Heterocyclic jak kinase inhibitors
04/08/2010WO2010037225A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2010US20100087429 Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use
04/08/2010US20100087424 Tricyclic nitrogen containing heterocycles as antibacterial agents
04/08/2010CA2738348A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/08/2010CA2738150A1 Novel fused aminodihydrothiazine derivative
04/08/2010CA2737217A1 Heterocyclic jak kinase inhibitors
04/07/2010EP2170907A2 Macrocycles and their uses
04/07/2010EP2170905A2 Sirtuin modulating thiazolopyridine compounds
04/07/2010EP2170065A1 Diphenyl substituted alkanes
04/07/2010EP1590340B1 Inhibitors of histone deacetylase
04/06/2010US7691888 Thiazolyl-dihydro-indazole
04/06/2010US7691877 Pharmaceuticals
04/06/2010US7691859 prenyl transferase inhibitors; e.g. 8-butyl-7-(3-(imidazol-5-yl)-1-oxopropyl)-2-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine; antitumor agents; cancer of breast, colon, pancreas, prostate, lung, ovarian, epidermal; hematopoietics; Ras-dependent tumor;
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors
04/01/2010WO2010036896A1 Hepatitis c virus inhibitors
04/01/2010US20100081650 Antimicrobial Compounds
03/2010
03/31/2010EP2168969A2 Racemization and Enantiomer Separation of Clopidogrel
03/31/2010EP2167510A1 Sirtuin modulating imidazothiazole compounds
03/31/2010EP2167509A1 Piperazine and ý1,4¨diazepan derivatives as nk antagonists
03/31/2010EP2167508A1 Compounds for treating duchenne muscular dystrophy
03/31/2010EP2167494A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010CN101687885A Fused thiazole derivatives as kinase inhibitors
03/31/2010CN101687827A aminodihydrothiazine derivatives substituted with cyclic groups
03/31/2010CN101687787A Inhibitors of iap
03/30/2010US7687627 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010CA2577525C Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 152